Belite Bio, Inc
BLTE
$183.16
-$9.69-5.03%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.32M | -10.10M | -10.10M | -10.10M | -10.10M |
| Total Depreciation and Amortization | -163.00K | -163.00K | -163.00K | -163.00K | -163.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.84M | 3.24M | 3.24M | 3.24M | 3.24M |
| Change in Net Operating Assets | 1.26M | 2.42M | 2.42M | 2.42M | 2.42M |
| Cash from Operations | -10.39M | -4.60M | -4.60M | -4.60M | -4.60M |
| Capital Expenditure | -178.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -303.56M | -26.01M | -26.01M | -26.01M | -26.01M |
| Cash from Investing | -303.73M | -26.01M | -26.01M | -26.01M | -26.01M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 132.99M | 39.16M | 39.16M | 39.16M | 39.16M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 377.13M | 613.00K | 613.00K | 613.00K | 613.00K |
| Cash from Financing | 510.12M | 39.78M | 39.78M | 39.78M | 39.78M |
| Foreign Exchange rate Adjustments | -101.00K | -277.00K | -277.00K | -277.00K | -277.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 195.90M | 8.88M | 8.88M | 8.88M | 8.88M |